Circulating Peptidome Is Strongly Altered in COVID-19 Patients
International Journal of Environmental Research and Public Health · 2023
DOI: 10.3390/ijerph20021564 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Environmental Research and Public Health, 2023. Verfasst von Gianluca Baldanzi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AGING Project—Department of Excellence—DIMET, Università del Piemonte Orientale, MIUR ITALY, Regione Piemonte FSC Azione 173 INFRA-P2 COVID, MS4CoV, TECHNOMED-HUB.
Abstract (Originalsprache)
Whilst the impact of coronavirus disease 2019 (COVID-19) on the host proteome, metabolome, and lipidome has been largely investigated in different bio-fluids, to date, the circulating peptidome remains unexplored. Thus, the present study aimed to apply an untargeted peptidomic approach to provide insight into alterations of circulating peptides in the development and severity of SARS-CoV-2 infection. The circulating peptidome from COVID-19 severe and mildly symptomatic patients and negative controls was characterized using LC-MS/MS analysis for identification and quantification purposes. Database search and statistical analysis allowed a complete characterization of the plasma peptidome and the detection of the most significant modulated peptides that were impacted by the infection. Our results highlighted not only that peptide abundance inversely correlates with disease severity, but also the involvement of biomolecules belonging to inflammatory, immune-response, and coagulation proteins/processes. Moreover, our data suggested a possible involvement of changes in protein degradation patterns. In the present research, for the first time, the untargeted peptidomic approach enabled the identification of circulating peptides potentially playing a crucial role in the progression of COVID-19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy.
- Center for Translational Research on Autoimmune and Allergic Diseases, University of Piemonte Orientale, 28100 Novara, Italy.
- Respiratory Unit, Sant'Andrea Hospital, 13100 Vercelli, Italy.
- Internal and Emergency Medicine Department, Department of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy.
- Department of Health Sciences, University of Piemonte Orientale, 28100 Novara, Italy.
ORCID-Profile: Gianluca Baldanzi, Beatrice Purghè, Pier Paolo Sainaghi, Roberta Rolla, Annalisa Chiocchetti, Mario Malerba
Förderung
- AGING Project—Department of Excellence—DIMET, Università del Piemonte Orientale, MIUR ITALY
- Regione Piemonte FSC Azione 173 INFRA-P2 COVID, MS4CoV
- TECHNOMED-HUB
- Consorzio Interuniversitario di Biotecnologie project “The Pandemic era”
Zitieren
APA
Baldanzi, G., Purghè, B., Ragnoli, B., Sainaghi, P. P., Rolla, R., Chiocchetti, A., Manfredi, M., & Malerba, M. (2023). Circulating Peptidome Is Strongly Altered in COVID-19 Patients. International Journal of Environmental Research and Public Health. https://doi.org/10.3390/ijerph20021564
Vancouver
Baldanzi G, Purghè B, Ragnoli B, Sainaghi PP, Rolla R, Chiocchetti A, et al. Circulating Peptidome Is Strongly Altered in COVID-19 Patients. International Journal of Environmental Research and Public Health. 2023. doi:10.3390/ijerph20021564
BibTeX
@article{Baldanzi2023,
author = {Baldanzi, Gianluca and Purghè, Beatrice and Ragnoli, Beatrice and Sainaghi, Pier Paolo and Rolla, Roberta and Chiocchetti, Annalisa and Manfredi, Marcello and Malerba, Mario},
title = {Circulating Peptidome Is Strongly Altered in COVID-19 Patients},
journal = {International Journal of Environmental Research and Public Health},
year = {2023},
doi = {10.3390/ijerph20021564}
}
EUVIMED